Oconee Gerd Presentation Key
•Download as ZIP, PDF•
0 likes•1 view
This document discusses the treatment of GERD and Barrett's esophagus. It outlines common symptoms of GERD like heartburn and difficulty swallowing. It also discusses potential complications like Barrett's esophagus and cancer if left untreated. The diagnosis involves medication trials and endoscopy. Barrett's esophagus is a pre-cancerous condition affecting the lining of the esophagus that requires surveillance and can be treated through lifestyle changes, medication, endoscopic procedures, or surgery with the goals of eliminating all abnormal cells and preventing progression to cancer while still requiring ongoing surveillance.
Report
Share
Report
Share
Recommended
2014 crohns colitis assoc concord hospital forum psc rupert leong
This document discusses primary sclerosing cholangitis (PSC), a chronic cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts. It provides details on the epidemiology, associated conditions, diagnosis, and treatment of PSC. Highlights include that PSC often co-occurs with inflammatory bowel disease, diagnosis involves cholangiography to detect bile duct abnormalities, and treatments like ursodeoxycholic acid and liver transplantation are discussed. The document also describes local data on PSC patients and initiatives to support research and patients through a new Australian Bowel Foundation.
Primary sclerosing cholangitis.drquiyum
Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by inflammation and fibrosis of the bile ducts that can progress to cirrhosis and liver cancer. It has a median survival time of 15 years and is the fifth most common reason for liver transplantation. PSC commonly affects males in their 40s and is associated with inflammatory bowel disease. Diagnosis involves clinical features, blood tests showing cholestasis, and imaging or biopsy of the bile ducts. Treatment includes medications like ursodeoxycholic acid and antibiotics, as well as endoscopic procedures and ultimately liver transplantation for advanced disease.
Primary Sclerosing Cholangitis (PSC)
This document provides an overview of primary sclerosing cholangitis (PSC), including:
- PSC affects less than 200,000 individuals in the US with higher rates in Northern Europe.
- The cause is unknown but likely involves genetic and immune factors. It is characterized by inflammation and fibrosis of the bile ducts.
- PSC often occurs with inflammatory bowel disease and increases the risk of cholangiocarcinoma and colon cancer.
- Diagnosis involves blood tests, imaging like MRCP, and may involve biopsy.
- There is no curative treatment but ursodeoxycholic acid may help. Liver transplantation is considered for advanced disease.
- Areas of research
Acute Mesenteric Ischaemia
Information about Bowel gangrene by Dr Dhaval Mangukiya.
Details of Bowel gangrene, Acute Mesenteric Ischaemia, Incidence, Challenges in diagnosing mesenteric ischemia, CT scan Angiography, Case, Learning Points, Future in Imaging, Surgery, SIDS Hospital, Thrombectomy, Postoperative and case etc.
https://drdhavalmangukiya.com/
http://www.youtube.com/c/DrDhavalMangukiyaGastrosurgeonSurat
https://gastrosurgerysurat.blogspot.com/
Primary Sclerosing Cholangitis (PSC)
Primary sclerosing cholangitis (PSC) is a chronic disease that slowly damages the bile ducts within the liver over many years, potentially leading to cirrhosis, liver failure, and cancer if left untreated. PSC has no known cause but may be related to infections or genetic factors. While many patients are asymptomatic initially, over time PSC can cause fatigue, itching, jaundice, abdominal pain, and other symptoms. The only cure is liver transplantation, though treatments can help manage symptoms and slow disease progression. Researchers continue working to better understand PSC and develop new treatment options.
Autoimmune cholangiopathies
This document discusses different types of autoimmune cholangiopathies: primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). PBC involves destruction of small and medium bile ducts by lymphocytes and plasma cells, leading to cirrhosis over years. It affects middle-aged women and is associated with antimitochondrial antibodies. PSC involves inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts, often in patients with inflammatory bowel disease. It is characterized by "onion skin" fibrosis and strictures seen on MRI. Both can progress to liver failure but PSC has a higher risk of cholangiocarcinoma. Secondary biliary
Multidisciplinary team in Management of Primary sclerosing Cholangitis
1. Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease characterized by inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts, leading to multifocal bile duct strictures.
2. PSC is diagnosed based on cholangiography showing characteristic bile duct changes along with elevated cholestatic liver enzymes and exclusion of secondary causes.
3. There is no established medical treatment for PSC, but ursodeoxycholic acid and immunosuppressants have been used to limited benefit. Endoscopic retrograde cholangiography can help relieve symptoms from dominant strictures.
If Presentation Asc
Intestinal failure results from various conditions that impair the ability of the small intestine to absorb enough nutrients and fluid. It is characterized by an inability to maintain nutritional and electrolyte balance. This retrospective study examined 59 patients treated for intestinal failure at a UK center between 2005-2007. It found that surgical management in a dedicated unit safely reduced dependence on total parenteral nutrition by 56% and permanent ostomy rates by 50% compared to previous studies. The length of remaining small bowel was the only factor predictive of post-operative nutrition requirements.
Recommended
2014 crohns colitis assoc concord hospital forum psc rupert leong
This document discusses primary sclerosing cholangitis (PSC), a chronic cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts. It provides details on the epidemiology, associated conditions, diagnosis, and treatment of PSC. Highlights include that PSC often co-occurs with inflammatory bowel disease, diagnosis involves cholangiography to detect bile duct abnormalities, and treatments like ursodeoxycholic acid and liver transplantation are discussed. The document also describes local data on PSC patients and initiatives to support research and patients through a new Australian Bowel Foundation.
Primary sclerosing cholangitis.drquiyum
Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by inflammation and fibrosis of the bile ducts that can progress to cirrhosis and liver cancer. It has a median survival time of 15 years and is the fifth most common reason for liver transplantation. PSC commonly affects males in their 40s and is associated with inflammatory bowel disease. Diagnosis involves clinical features, blood tests showing cholestasis, and imaging or biopsy of the bile ducts. Treatment includes medications like ursodeoxycholic acid and antibiotics, as well as endoscopic procedures and ultimately liver transplantation for advanced disease.
Primary Sclerosing Cholangitis (PSC)
This document provides an overview of primary sclerosing cholangitis (PSC), including:
- PSC affects less than 200,000 individuals in the US with higher rates in Northern Europe.
- The cause is unknown but likely involves genetic and immune factors. It is characterized by inflammation and fibrosis of the bile ducts.
- PSC often occurs with inflammatory bowel disease and increases the risk of cholangiocarcinoma and colon cancer.
- Diagnosis involves blood tests, imaging like MRCP, and may involve biopsy.
- There is no curative treatment but ursodeoxycholic acid may help. Liver transplantation is considered for advanced disease.
- Areas of research
Acute Mesenteric Ischaemia
Information about Bowel gangrene by Dr Dhaval Mangukiya.
Details of Bowel gangrene, Acute Mesenteric Ischaemia, Incidence, Challenges in diagnosing mesenteric ischemia, CT scan Angiography, Case, Learning Points, Future in Imaging, Surgery, SIDS Hospital, Thrombectomy, Postoperative and case etc.
https://drdhavalmangukiya.com/
http://www.youtube.com/c/DrDhavalMangukiyaGastrosurgeonSurat
https://gastrosurgerysurat.blogspot.com/
Primary Sclerosing Cholangitis (PSC)
Primary sclerosing cholangitis (PSC) is a chronic disease that slowly damages the bile ducts within the liver over many years, potentially leading to cirrhosis, liver failure, and cancer if left untreated. PSC has no known cause but may be related to infections or genetic factors. While many patients are asymptomatic initially, over time PSC can cause fatigue, itching, jaundice, abdominal pain, and other symptoms. The only cure is liver transplantation, though treatments can help manage symptoms and slow disease progression. Researchers continue working to better understand PSC and develop new treatment options.
Autoimmune cholangiopathies
This document discusses different types of autoimmune cholangiopathies: primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). PBC involves destruction of small and medium bile ducts by lymphocytes and plasma cells, leading to cirrhosis over years. It affects middle-aged women and is associated with antimitochondrial antibodies. PSC involves inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts, often in patients with inflammatory bowel disease. It is characterized by "onion skin" fibrosis and strictures seen on MRI. Both can progress to liver failure but PSC has a higher risk of cholangiocarcinoma. Secondary biliary
Multidisciplinary team in Management of Primary sclerosing Cholangitis
1. Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease characterized by inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts, leading to multifocal bile duct strictures.
2. PSC is diagnosed based on cholangiography showing characteristic bile duct changes along with elevated cholestatic liver enzymes and exclusion of secondary causes.
3. There is no established medical treatment for PSC, but ursodeoxycholic acid and immunosuppressants have been used to limited benefit. Endoscopic retrograde cholangiography can help relieve symptoms from dominant strictures.
If Presentation Asc
Intestinal failure results from various conditions that impair the ability of the small intestine to absorb enough nutrients and fluid. It is characterized by an inability to maintain nutritional and electrolyte balance. This retrospective study examined 59 patients treated for intestinal failure at a UK center between 2005-2007. It found that surgical management in a dedicated unit safely reduced dependence on total parenteral nutrition by 56% and permanent ostomy rates by 50% compared to previous studies. The length of remaining small bowel was the only factor predictive of post-operative nutrition requirements.
Primary Sclerosing Cholangitis (PSC)
Primary sclerosing cholangitis is a chronic progressive disease characterized by inflammation and fibrosis of the bile ducts. It has unknown causes but likely involves genetic and immunological factors. The disease varies in progression and can result in complications like end-stage liver disease, portal hypertension, cholangitis, or cholangiocarcinoma. While most patients with primary sclerosing cholangitis have inflammatory bowel disease, only a minority of inflammatory bowel disease patients develop primary sclerosing cholangitis. There are no proven effective treatments, so management focuses on supportive care and transplantation may be considered for complications.
NAFLD, NASH
The document discusses non-alcoholic fatty liver disease (NAFLD), which includes a spectrum of conditions from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is strongly associated with obesity and metabolic syndrome. The prevalence of NAFLD is increasing globally and varies from 5-30% in different regions. Diagnosis requires imaging and liver biopsy. Treatment focuses on lifestyle modifications and medications to improve insulin resistance.
GIT Autoimmune cholestatic liver diseases.
This document discusses several autoimmune cholestatic liver diseases including Primary Biliary Cirrhosis (PBC), Primary Sclerosing Cholangitis (PSC), and Autoimmune Hepatitis (AIH). PBC primarily affects middle-aged women and is diagnosed through blood tests showing antimitochondrial antibodies and liver biopsy. Ursodeoxycholic acid treatment improves symptoms and delays disease progression. PSC often co-occurs with inflammatory bowel disease and is diagnosed through imaging showing bile duct abnormalities. Management focuses on treating complications but liver transplantation may be required. AIH mainly affects young women and jaundice or elevated liver enzymes indicate further evaluation including biopsy.
Git j club psc16.
Possible causes of primary sclerosing cholangitis are unclear but may involve genetic and environmental factors. It is characterized by persistent inflammation and fibrosis of the bile ducts. There is no effective medical therapy, and the disease can progress to end-stage liver disease requiring transplantation. It is strongly associated with inflammatory bowel disease and carries an increased risk of colon, bile duct, and gallbladder cancers.
Autoimmune Liver Disease - Kuwait
The document discusses three main autoimmune liver diseases: autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. It provides details on the gender, age, associated conditions, affected bile ducts, diagnostic markers, and histological features of each disease. Key differences between primary biliary cirrhosis and primary sclerosing cholangitis are highlighted.
Primary biliary cirrhosis and autoimmune hepatitis 20120902
This document summarizes a case of primary biliary cirrhosis (PBC) in a 66-year-old man who presented with intermittent pruritus for 8 years. Laboratory tests showed elevated liver enzymes and positive anti-mitochondrial antibodies, confirming the diagnosis of PBC. Liver biopsy showed features characteristic of PBC including destruction of bile duct epithelium and lymphocyte infiltration. The document then provides information on the epidemiology, risk factors, pathogenesis, natural history, diagnosis, treatment and prognosis of PBC.
Hepatitis C virus & chronic kidney diseases
This document discusses hepatitis C virus (HCV) and its relationship to chronic kidney disease. It covers HCV diagnosis in chronic kidney disease patients, HCV-related glomerulonephritis, HCV in dialysis patients, and HCV and kidney transplantation. Key points include that HCV prevalence is higher in dialysis populations, HCV increases the risk of death in dialysis patients, and universal precautions can prevent HCV transmission in hemodialysis units. Cryoglobulinemia is also discussed as it relates to HCV infection and kidney involvement.
Primary Biliary Cholangitis
This document summarizes key aspects of primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis. It discusses the epidemiology, risk factors, natural history, presentation, diagnosis and management of PBC. If left untreated, PBC progresses through several clinical phases over many years, eventually leading to liver failure and death in some patients. Prognosis is generally better in asymptomatic patients than in those with symptoms.
NAFLD
This document summarizes non-alcoholic fatty liver disease (NAFLD), which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is strongly associated with obesity, diabetes, and metabolic syndrome. While the pathogenesis is not fully understood, theories involve insulin resistance and interactions between the gut and liver. Diagnosis involves blood tests, ultrasound, or biopsy. Limited treatment options include weight loss, vitamin E (for NASH), and pioglitazone. Ongoing research is exploring new drug targets to treat NAFLD and prevent progression to end-stage liver disease.
Git j club PU bleed16.
This document summarizes guidelines for the management of upper gastrointestinal bleeding (UGIB). It discusses initial patient assessment and risk stratification, the role of endoscopy within 24 hours, endoscopic findings that predict risk of rebleeding, endoscopic therapies, post-endoscopy management including PPI infusion, and strategies to prevent recurrent bleeding related to causes like H. pylori and NSAID use. Endoscopy is important to determine the source of bleeding and apply therapies when needed to reduce risks of additional bleeding, surgery, and mortality. Post-endoscopy care involves PPI therapy and follow up based on risk level.
Zollinger ellison seminar
Zollinger-Ellison syndrome is caused by gastrin-secreting tumors called gastrinomas, which produce high levels of the hormone gastrin. This excess gastrin stimulates excess stomach acid production, leading to ulcers in the stomach and small intestine. Gastrinomas most commonly arise in the duodenum or pancreas. Treatment focuses on acid suppression with proton pump inhibitors to relieve symptoms and prevent new ulcers from forming. For malignant or metastatic gastrinomas, surgical removal can be attempted when possible, while other treatments like chemotherapy, somatostatin analogs, or targeted therapies may help control tumor growth.
GIT J Club: NAFLD.
This document discusses nonalcoholic fatty liver disease (NAFLD). It begins by explaining that NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis. Insulin resistance plays a key role in the metabolic abnormalities seen in NAFLD. The pathogenesis of NASH is not fully understood. Currently, there are no approved therapies, so treatment focuses on lifestyle modifications like weight loss and exercise to improve comorbidities. The prevalence of NAFLD is increasing due to the rising obesity epidemic.
Git j club secondaries.
This document discusses gastrointestinal (GI) tract metastases from various primary cancers. It notes that melanoma, lung cancer, and breast cancer most commonly metastasize to the GI tract. The presentation of GI metastases can be variable and nonspecific, with gastrointestinal bleeding or abdominal pain being most common. Endoscopically, metastases may appear as solitary or multiple nodules, ulcers, or subepithelial masses. Diagnosis can be difficult due to the often prolonged time between primary tumor and metastasis, as well as benign-appearing lesions that can mimic primary GI cancers. Advanced imaging like CT and EUS-guided biopsy help confirm diagnoses. Familiarity with metastatic patterns from common primary cancers aids in detection and prevents misdiag
Gi malignancy in india
According to studies in India:
1) Esophageal cancer is most commonly squamous cell carcinoma, with adenocarcinoma accounting for about 8% of cases. Risk factors for esophageal cancer include HPV infection and p53 mutations.
2) Stomach cancer is most prevalent in Northeast India, particularly in Mizoram. Risk factors include H. pylori infection, pickled foods, smoked foods, and GSTM1 mutations.
3) Liver cancer is usually hepatocellular carcinoma developing in cirrhotic livers. Risk factors are HBV, HCV, alcohol, and dual infections.
4) Gallbladder cancer incidence varies by region but presents at advanced stages with poor survival rates
Non alcoholic fatty liver disease(NAFLD)
Non alcoholic fatty liver disease, NAFLD, non alcoholic liver disease, definition, spectrum, definition of NAFLD, prevalence, causes, pathogenesis, metabolic syndrome, insulin resistance, insulin resistance tests, multi hit hypothesis, Diagnosis, medications, pharmacotherapy, aasld recommendations, vitaminE, prognosis, complication,
Acute abdomen
The document discusses the diagnosis and treatment of acute abdomen conditions. It outlines the importance of recognizing signs and symptoms, obtaining a thorough medical history, and conducting a physical examination. Common causes of acute abdomen that require urgent surgery are mentioned. Diagnostic studies and potential surgical procedures are also listed. Factors like age, gender, and previous medical history should be considered in diagnosis.
Nonalcoholic Steatohepatitis (NASH) Review
An updated review on nonalcoholic steatohepatitis, epidemiology, pathology, diagnosis, treatment modalities and current clinical trials are reviewed.
New England Journal of Medicine review article from November 2017 entitled "Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis" was extensively cited, please see references on the last slide (DOI: 10.1056/NEJMra1503519).
This is purely for educational purposes; I do not diagnose, treat, or offer patient-specific advice by sharing these slides.
NON ALCOHOLIC FATTY LIVER DISEASE
Non-alcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in the liver in the absence of excessive alcohol use. It ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD affects 25% of Americans and its prevalence is increasing worldwide. Risk factors include obesity, diabetes, and metabolic syndrome. Diagnosis involves blood tests and imaging, while biopsy is needed to diagnose NASH. Treatment focuses on lifestyle changes like weight loss and exercise. Medications being investigated include antioxidants, diabetes medications, cytoprotective agents, and lipid lowering drugs, but more research is still needed to determine the optimal pharmacotherapy.
HCC MANGEMENT(RAD ONCO)
This document summarizes the management of hepatocellular carcinoma (HCC). It discusses the incidence, biological markers, staging evaluations, and treatment options for HCC depending on the stage. For early stage disease (BCLC stages 0 and A), primary curative treatments include surgical resection or liver transplantation. For intermediate stage disease (BCLC stage B), locoregional therapies like radiofrequency ablation, microwave ablation, stereotactic body radiation therapy, and selective internal radiation therapy are options. For more advanced HCC (BCLC stages C and D), palliative treatments like transarterial chemoembolization or systemic therapies like sorafenib are utilized. SBRT is also explored as a bridge to liver transplantation
Ulcerative colitis
UC is an idiopathic IBD that affects the colonic mucosa.
Hallmark of UC is bloody diarrhea often with prominent symptoms of rectal urgency and tenesmus.
The clinical course is marked by exacerbations and remissions.
The diagnosis of UC is suspected on clinical grounds and supported by the appropriate findings on
Proctosigmoidoscopy or colonoscopy
Biopsy
By negative stool examination for infectious causes
IBD lecture ppt FINAL.pptx
This document provides an overview of inflammatory bowel disease (IBD). It discusses the spectrum of IBD, which includes ulcerative colitis and Crohn's disease. The pathogenesis of IBD involves genetic, environmental, immune, and microbial factors that lead to chronic gut inflammation. Ulcerative colitis causes inflammation of the colon only, while Crohn's disease can impact any part of the gastrointestinal tract. The document outlines the clinical presentation, diagnosis, and management of both conditions, including medications like 5-aminosalicylic acid and biological therapies. It emphasizes achieving mucosal healing as the primary treatment goal for controlling symptoms and modifying the long-term course of IBD.
Digestive Tract Cancers & How to Prevent Them
Digestive cancers are a major health problem in Singapore, accounting for 3,000 new cases and 5 of the top 10 cancer deaths annually. Common digestive symptoms affect many adults but only 10% see a doctor. Serious symptoms requiring medical attention include those in people over age 45, weight loss, bleeding, and family history of cancer. Specialists perform colonoscopies and advanced endoscopy techniques to detect cancers and pre-cancerous growths early and remove them, but some lesions are still missed. New technologies allow for improved cancer screening and prevention.
More Related Content
What's hot
Primary Sclerosing Cholangitis (PSC)
Primary sclerosing cholangitis is a chronic progressive disease characterized by inflammation and fibrosis of the bile ducts. It has unknown causes but likely involves genetic and immunological factors. The disease varies in progression and can result in complications like end-stage liver disease, portal hypertension, cholangitis, or cholangiocarcinoma. While most patients with primary sclerosing cholangitis have inflammatory bowel disease, only a minority of inflammatory bowel disease patients develop primary sclerosing cholangitis. There are no proven effective treatments, so management focuses on supportive care and transplantation may be considered for complications.
NAFLD, NASH
The document discusses non-alcoholic fatty liver disease (NAFLD), which includes a spectrum of conditions from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is strongly associated with obesity and metabolic syndrome. The prevalence of NAFLD is increasing globally and varies from 5-30% in different regions. Diagnosis requires imaging and liver biopsy. Treatment focuses on lifestyle modifications and medications to improve insulin resistance.
GIT Autoimmune cholestatic liver diseases.
This document discusses several autoimmune cholestatic liver diseases including Primary Biliary Cirrhosis (PBC), Primary Sclerosing Cholangitis (PSC), and Autoimmune Hepatitis (AIH). PBC primarily affects middle-aged women and is diagnosed through blood tests showing antimitochondrial antibodies and liver biopsy. Ursodeoxycholic acid treatment improves symptoms and delays disease progression. PSC often co-occurs with inflammatory bowel disease and is diagnosed through imaging showing bile duct abnormalities. Management focuses on treating complications but liver transplantation may be required. AIH mainly affects young women and jaundice or elevated liver enzymes indicate further evaluation including biopsy.
Git j club psc16.
Possible causes of primary sclerosing cholangitis are unclear but may involve genetic and environmental factors. It is characterized by persistent inflammation and fibrosis of the bile ducts. There is no effective medical therapy, and the disease can progress to end-stage liver disease requiring transplantation. It is strongly associated with inflammatory bowel disease and carries an increased risk of colon, bile duct, and gallbladder cancers.
Autoimmune Liver Disease - Kuwait
The document discusses three main autoimmune liver diseases: autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. It provides details on the gender, age, associated conditions, affected bile ducts, diagnostic markers, and histological features of each disease. Key differences between primary biliary cirrhosis and primary sclerosing cholangitis are highlighted.
Primary biliary cirrhosis and autoimmune hepatitis 20120902
This document summarizes a case of primary biliary cirrhosis (PBC) in a 66-year-old man who presented with intermittent pruritus for 8 years. Laboratory tests showed elevated liver enzymes and positive anti-mitochondrial antibodies, confirming the diagnosis of PBC. Liver biopsy showed features characteristic of PBC including destruction of bile duct epithelium and lymphocyte infiltration. The document then provides information on the epidemiology, risk factors, pathogenesis, natural history, diagnosis, treatment and prognosis of PBC.
Hepatitis C virus & chronic kidney diseases
This document discusses hepatitis C virus (HCV) and its relationship to chronic kidney disease. It covers HCV diagnosis in chronic kidney disease patients, HCV-related glomerulonephritis, HCV in dialysis patients, and HCV and kidney transplantation. Key points include that HCV prevalence is higher in dialysis populations, HCV increases the risk of death in dialysis patients, and universal precautions can prevent HCV transmission in hemodialysis units. Cryoglobulinemia is also discussed as it relates to HCV infection and kidney involvement.
Primary Biliary Cholangitis
This document summarizes key aspects of primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis. It discusses the epidemiology, risk factors, natural history, presentation, diagnosis and management of PBC. If left untreated, PBC progresses through several clinical phases over many years, eventually leading to liver failure and death in some patients. Prognosis is generally better in asymptomatic patients than in those with symptoms.
NAFLD
This document summarizes non-alcoholic fatty liver disease (NAFLD), which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is strongly associated with obesity, diabetes, and metabolic syndrome. While the pathogenesis is not fully understood, theories involve insulin resistance and interactions between the gut and liver. Diagnosis involves blood tests, ultrasound, or biopsy. Limited treatment options include weight loss, vitamin E (for NASH), and pioglitazone. Ongoing research is exploring new drug targets to treat NAFLD and prevent progression to end-stage liver disease.
Git j club PU bleed16.
This document summarizes guidelines for the management of upper gastrointestinal bleeding (UGIB). It discusses initial patient assessment and risk stratification, the role of endoscopy within 24 hours, endoscopic findings that predict risk of rebleeding, endoscopic therapies, post-endoscopy management including PPI infusion, and strategies to prevent recurrent bleeding related to causes like H. pylori and NSAID use. Endoscopy is important to determine the source of bleeding and apply therapies when needed to reduce risks of additional bleeding, surgery, and mortality. Post-endoscopy care involves PPI therapy and follow up based on risk level.
Zollinger ellison seminar
Zollinger-Ellison syndrome is caused by gastrin-secreting tumors called gastrinomas, which produce high levels of the hormone gastrin. This excess gastrin stimulates excess stomach acid production, leading to ulcers in the stomach and small intestine. Gastrinomas most commonly arise in the duodenum or pancreas. Treatment focuses on acid suppression with proton pump inhibitors to relieve symptoms and prevent new ulcers from forming. For malignant or metastatic gastrinomas, surgical removal can be attempted when possible, while other treatments like chemotherapy, somatostatin analogs, or targeted therapies may help control tumor growth.
GIT J Club: NAFLD.
This document discusses nonalcoholic fatty liver disease (NAFLD). It begins by explaining that NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis. Insulin resistance plays a key role in the metabolic abnormalities seen in NAFLD. The pathogenesis of NASH is not fully understood. Currently, there are no approved therapies, so treatment focuses on lifestyle modifications like weight loss and exercise to improve comorbidities. The prevalence of NAFLD is increasing due to the rising obesity epidemic.
Git j club secondaries.
This document discusses gastrointestinal (GI) tract metastases from various primary cancers. It notes that melanoma, lung cancer, and breast cancer most commonly metastasize to the GI tract. The presentation of GI metastases can be variable and nonspecific, with gastrointestinal bleeding or abdominal pain being most common. Endoscopically, metastases may appear as solitary or multiple nodules, ulcers, or subepithelial masses. Diagnosis can be difficult due to the often prolonged time between primary tumor and metastasis, as well as benign-appearing lesions that can mimic primary GI cancers. Advanced imaging like CT and EUS-guided biopsy help confirm diagnoses. Familiarity with metastatic patterns from common primary cancers aids in detection and prevents misdiag
Gi malignancy in india
According to studies in India:
1) Esophageal cancer is most commonly squamous cell carcinoma, with adenocarcinoma accounting for about 8% of cases. Risk factors for esophageal cancer include HPV infection and p53 mutations.
2) Stomach cancer is most prevalent in Northeast India, particularly in Mizoram. Risk factors include H. pylori infection, pickled foods, smoked foods, and GSTM1 mutations.
3) Liver cancer is usually hepatocellular carcinoma developing in cirrhotic livers. Risk factors are HBV, HCV, alcohol, and dual infections.
4) Gallbladder cancer incidence varies by region but presents at advanced stages with poor survival rates
Non alcoholic fatty liver disease(NAFLD)
Non alcoholic fatty liver disease, NAFLD, non alcoholic liver disease, definition, spectrum, definition of NAFLD, prevalence, causes, pathogenesis, metabolic syndrome, insulin resistance, insulin resistance tests, multi hit hypothesis, Diagnosis, medications, pharmacotherapy, aasld recommendations, vitaminE, prognosis, complication,
Acute abdomen
The document discusses the diagnosis and treatment of acute abdomen conditions. It outlines the importance of recognizing signs and symptoms, obtaining a thorough medical history, and conducting a physical examination. Common causes of acute abdomen that require urgent surgery are mentioned. Diagnostic studies and potential surgical procedures are also listed. Factors like age, gender, and previous medical history should be considered in diagnosis.
Nonalcoholic Steatohepatitis (NASH) Review
An updated review on nonalcoholic steatohepatitis, epidemiology, pathology, diagnosis, treatment modalities and current clinical trials are reviewed.
New England Journal of Medicine review article from November 2017 entitled "Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis" was extensively cited, please see references on the last slide (DOI: 10.1056/NEJMra1503519).
This is purely for educational purposes; I do not diagnose, treat, or offer patient-specific advice by sharing these slides.
NON ALCOHOLIC FATTY LIVER DISEASE
Non-alcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in the liver in the absence of excessive alcohol use. It ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD affects 25% of Americans and its prevalence is increasing worldwide. Risk factors include obesity, diabetes, and metabolic syndrome. Diagnosis involves blood tests and imaging, while biopsy is needed to diagnose NASH. Treatment focuses on lifestyle changes like weight loss and exercise. Medications being investigated include antioxidants, diabetes medications, cytoprotective agents, and lipid lowering drugs, but more research is still needed to determine the optimal pharmacotherapy.
HCC MANGEMENT(RAD ONCO)
This document summarizes the management of hepatocellular carcinoma (HCC). It discusses the incidence, biological markers, staging evaluations, and treatment options for HCC depending on the stage. For early stage disease (BCLC stages 0 and A), primary curative treatments include surgical resection or liver transplantation. For intermediate stage disease (BCLC stage B), locoregional therapies like radiofrequency ablation, microwave ablation, stereotactic body radiation therapy, and selective internal radiation therapy are options. For more advanced HCC (BCLC stages C and D), palliative treatments like transarterial chemoembolization or systemic therapies like sorafenib are utilized. SBRT is also explored as a bridge to liver transplantation
What's hot (19)
Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902
Similar to Oconee Gerd Presentation Key
Ulcerative colitis
UC is an idiopathic IBD that affects the colonic mucosa.
Hallmark of UC is bloody diarrhea often with prominent symptoms of rectal urgency and tenesmus.
The clinical course is marked by exacerbations and remissions.
The diagnosis of UC is suspected on clinical grounds and supported by the appropriate findings on
Proctosigmoidoscopy or colonoscopy
Biopsy
By negative stool examination for infectious causes
IBD lecture ppt FINAL.pptx
This document provides an overview of inflammatory bowel disease (IBD). It discusses the spectrum of IBD, which includes ulcerative colitis and Crohn's disease. The pathogenesis of IBD involves genetic, environmental, immune, and microbial factors that lead to chronic gut inflammation. Ulcerative colitis causes inflammation of the colon only, while Crohn's disease can impact any part of the gastrointestinal tract. The document outlines the clinical presentation, diagnosis, and management of both conditions, including medications like 5-aminosalicylic acid and biological therapies. It emphasizes achieving mucosal healing as the primary treatment goal for controlling symptoms and modifying the long-term course of IBD.
Digestive Tract Cancers & How to Prevent Them
Digestive cancers are a major health problem in Singapore, accounting for 3,000 new cases and 5 of the top 10 cancer deaths annually. Common digestive symptoms affect many adults but only 10% see a doctor. Serious symptoms requiring medical attention include those in people over age 45, weight loss, bleeding, and family history of cancer. Specialists perform colonoscopies and advanced endoscopy techniques to detect cancers and pre-cancerous growths early and remove them, but some lesions are still missed. New technologies allow for improved cancer screening and prevention.
Knowing Cancer of Colon
The document discusses colorectal cancer, including its development from polyps, risk factors, symptoms, screening and prevention methods like colonoscopy, and treatment options like surgery, chemotherapy, and radiation therapy. Colorectal cancer is the third most common cancer and second leading cause of cancer death, developing from polyps in the colon or rectum that grow uncontrollably over time if not removed. Screening through tests such as colonoscopy is important for early detection and prevention of colorectal cancer.
Presentation
This document summarizes chronic conditions of the bowel, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). IBS is characterized by abdominal pain and altered bowel habits without an organic cause. IBS is subtyped based on stool consistency. IBD includes ulcerative colitis and Crohn's disease, which are chronic inflammatory conditions of the gastrointestinal tract that are treated with medications like aminosalicylates, corticosteroids, immunomodulators, and biologics. Treatment depends on disease location and severity. Biologics are effective but carry risks of serious infections and lymphomas.
Bud chairi syndrome Dr Asif Zaidi MBBS FCPS
Budd Chiari syndrome is caused by obstruction of hepatic venous outflow. It can present acutely, subacutely, or chronically with symptoms like ascites, hepatomegaly, and abdominal pain. Doppler ultrasound and MRI are used to diagnose by identifying blockages of hepatic veins or IVC. Treatment involves identifying underlying causes, relieving pressure through procedures like angioplasty and stenting, and managing complications. Hepatic venoplasty can successfully treat selected patients with improvement in outcomes, avoiding the need for more invasive procedures or transplantation.
Calling All Women! Get Smart About Your Health - Roohi Khanna, DO - Montclair...
Did you know that the health decisions a woman makes in her 20s will have a direct impact on her health later in life? Now is the time to make your health a priority! Join us to learn some simple steps you can take now that will improve your health in the future. We will discuss important routine health screenings a woman should receive throughout her life and provide tips and positive health habits for improving health at any age.
Gi tumor
This 55-year-old male presented with melena, weakness, weight loss, and anemia over the past year. Endoscopy revealed a polypoidal stomach mass, and biopsy showed a gastrointestinal stromal tumor (GIST). CT scan found a 5.7x6.8 cm stomach wall mass without metastases. He underwent a sleeve gastrectomy surgery to remove the tumor. Histopathology of the tumor was consistent with a GIST, and he was referred for adjuvant imatinib therapy due to risk of recurrence or metastases.
CA Esophagus-Presentation and its Diagnosis 1.pptx
CT scan and EUS are important investigations for esophageal cancer to accurately stage the tumor and assess involvement of nearby structures and lymph nodes. EUS in particular provides very detailed images and is better than CT for assessing depth of tumor invasion and detecting small lymph nodes that may be missed on CT. Accurate staging is important for determining resectability and treatment planning.
Acute Diverticulitis.pptx
Acute Diverticulitis is an inflammation of diverticula in the large intestine that commonly occurs in the sigmoid colon. It presents with lower abdominal pain, fever, and changes in bowel habits. Diagnosis is made through CT scan findings and blood tests. Treatment depends on severity and complications, ranging from oral antibiotics for uncomplicated cases to emergency surgery for perforated diverticulitis with peritonitis. Long term risks include recurrence requiring further treatment or surgery.
Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) includes chronic disorders that cause inflammation or ulceration of the large and small intestines. The two main types are Crohn's disease and ulcerative colitis. Crohn's disease can affect any part of the gastrointestinal tract and causes transmural inflammation. Ulcerative colitis causes ulceration and inflammation of the inner lining of the colon and rectum. Both diseases are associated with diarrhea, abdominal pain, and weight loss. Diagnosis involves blood tests, endoscopy, and biopsy. Treatment depends on severity but may include medications like 5-aminosalicylates, corticosteroids, antibiotics, immunosuppressants, or biological therapy. Surgery is considered for severe
Prostate diseases for General practitioners
Prostate diseases are common among aging men. Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate that leads to urinary symptoms. BPH prevalence increases with age, affecting 20% of men aged 41-50 and over 80% of men aged 81-90. Treatment options for BPH include lifestyle changes, watchful waiting, medical therapy with alpha blockers or 5-alpha-reductase inhibitors, and surgical procedures like TURP. Prostate cancer is the second most common cancer in men. Screening includes a PSA test and digital rectal exam. Treatment depends on cancer risk and may include active surveillance, surgery, radiation, or hormone therapy.
Colon cancer awareness
This is a detailed presentation about Colon Cancer awareness,
Includes etiology, clinical presentation and prevention strategy.
Colon cancer awareness
Colorectal cancer is the third most common cancer in the US and the second leading cause of cancer death. Screening and removal of precancerous polyps can prevent colorectal cancer. Regular screening is recommended starting at age 50 and can detect cancers early when they are most treatable. Lifestyle factors like diet, exercise, weight control and not smoking can significantly impact colorectal cancer risk.
Ca pancreas [autosaved]
A 63-year-old male presented with epigastric pain radiating to the back, abdominal distention, vomiting and jaundice. Laboratory tests showed elevated bilirubin and liver enzymes. CT scan revealed a 3.5 cm x 3.7 cm pancreatic head mass and multiple liver nodules, indicating stage IV pancreatic cancer with liver metastasis. The patient was diagnosed with advanced pancreatic cancer based on imaging and laboratory findings.
GERD and Barrett esophagus.pptx · version 1.pptx
GERD is a common condition where stomach acid refluxes into the esophagus. It affects around 13% of the global population. Risk factors include advancing age, obesity, hiatal hernia, smoking, and certain foods. GERD occurs when there is an imbalance between protective factors in the esophagus and aggressive factors like acid and pepsin from the stomach. Symptoms range from heartburn to complications like esophagitis, stricture, and Barrett's esophagus. Treatment involves lifestyle modifications, antacids, H2 blockers, and PPIs. For severe cases, surgery may be considered to reinforce the lower esophageal sphincter. Endoscopic surveillance is important for monitoring Barrett
Hepatocellular carcinomas
This document provides an overview of hepatocellular carcinoma (HCC). It discusses the anatomy, epidemiology, screening, diagnosis, staging and management of HCC. HCC is commonly caused by viral hepatitis and cirrhosis. Diagnosis involves imaging such as ultrasound, CT or MRI showing characteristic arterial enhancement and venous washout. Staging systems include AJCC, Okuda, CLIP and BCLC which incorporate tumor burden, liver function and performance status. Management options include surgical resection, liver transplantation, ablation and arterially directed therapies like TACE.
Colorectal Cancer
Colorectal cancer is extremely common. Symptoms include blood in the stool and change in bowel habits. Screening using one of several methods is recommended for appropriate populations. Diagnosis is by colonoscopy. Treatment is surgical resection and chemotherapy for nodal involvement.
Lets get healthy - Dr SanjivHaribhakti
The document discusses the effects of aging on the digestive system. It states that as people age, the esophagus and stomach are less able to contract strongly and accommodate large amounts of food. Absorption in the small intestine changes little with age, but lactase production decreases, causing lactose intolerance. The liver shows some functional decline with aging as well. The document provides details on specific changes that occur in different parts of the digestive system as people get older.
Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBD) include ulcerative colitis and Crohn's disease, which cause chronic inflammation in the intestines. Ulcerative colitis affects only the colon, causing ulcers, while Crohn's disease can impact any part of the digestive tract and deeper layers. Both have no known cause but involve genetic, immune, microbial, and psychosocial factors. Common symptoms are diarrhea, abdominal pain, and rectal bleeding. Diagnosis involves blood tests, endoscopy, imaging, and biopsy. Treatment focuses on medications to reduce inflammation like 5-aminosalicylates, corticosteroids, antibiotics, immunosuppressants, and biological therapies. Surgery may be needed for complications or drug
Similar to Oconee Gerd Presentation Key (20)
Calling All Women! Get Smart About Your Health - Roohi Khanna, DO - Montclair...
Calling All Women! Get Smart About Your Health - Roohi Khanna, DO - Montclair...
CA Esophagus-Presentation and its Diagnosis 1.pptx
CA Esophagus-Presentation and its Diagnosis 1.pptx
Recently uploaded
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
ABDOMINAL TRAUMA in pediatrics part one.
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Light House Retreats: Plant Medicine Retreat Europe
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Non-respiratory Functions of the Lungs.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Best Ayurvedic medicine for Gas and Indigestion
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdf
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Valuable Content of Human Anatomy and Physiology of Urinary system as per PCI Syllabus for Pharmacy and PharmD Students.
Recently uploaded (20)
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Oconee Gerd Presentation Key
- 1. Normal
- 2. Treatment of GERD Wilcotte C Rahming, M.D. Oconee Medical Center
- 3. SYMPTOMS • Heartburn • Bleeding • Pain while swallowing • Difficulty swallowing • Weight loss
- 4. COMPLICATIONS • Barrett’s • Erosion • Obstruction from scarring • Cancer
- 5. DIAGNOSIS • Medication trial • Endoscopy
- 6. Barrett’s Esophagus • Affects the lining of the esophagus • 3.3 million adults > 50 • Pre-cancerous • 30-125 X > • Incidence increase 6 fold
- 7. Barrett’s Esophagus • 13% Caucasian men > 50 • 25% > 50 w/o Sx’s • 44% adults have Sx’s monthly • 18% weekly
- 12. SURVEILLANCE • No dysplasia every 3 years • LGD 6 - 12 months • HGD every 3 months
- 13. TREATMENT • Lifestyle change • Medication • Endoscopic • Surgery
- 14. ENDOSCOPY • RFA • APC • PDT • CSA
- 15. GOALS • Eliminate all IM • Prevent progression NDBE/LGD to HGD • HGD to cancer • Complete eradication of BE • Not to eliminate need for surveillance